*. Bmi-?-25 and . °°, 9) 6 (9.8) ** 3 (3.1) ** Abdominal Obesity 319 (53.0) 11 (28.2) ** 19 (26.0) ** male AO distribution 196 (32.6) 1 (6.7) * 0 (0.0) ** female AO distribution 423 (70.4) 10 (41.7) ** 19 (48.7) ** Data are expressed as n (and proportion); comparison with GGP (Guadeloupean general population, pp.329-54

D. Rees, T. Williams, and M. Gladwin, Sickle-cell disease, The Lancet, vol.376, issue.9757, pp.2018-2049, 2010.
DOI : 10.1016/S0140-6736(10)61029-X
URL : https://hal.archives-ouvertes.fr/hal-00552602

J. Schnog, A. Duits, F. Muskiet, H. Ten-cate, R. Rojer et al., Sickle cell disease; a general overview, Neth J Med, vol.62, pp.364-74, 2004.

F. Lionnet, N. Hammoudi, K. Stojanovic, V. Avellino, G. Grateau et al., Hemoglobin sickle cell disease complications: a clinical study of 179 cases, Haematologica, vol.97, issue.8, pp.1136-1177, 2012.
DOI : 10.3324/haematol.2011.055202

N. Lemonne, Y. Lamarre, R. M. Hardy-dessources, M. Lionnet, F. Waltz et al., Impaired blood rheology plays a role in the chronic disorders associated with sickle cell-hemoglobin C disease, Haematologica, vol.99, issue.5, pp.74-79, 2014.
DOI : 10.3324/haematol.2014.104745

J. Sasaki, M. Waterman, and G. Cottam, Decreased apolipoprotein A-I and B content in plasma of individuals with sickle cell anemia, Clin Chem, vol.32, pp.226-233, 1986.

Z. Rahimi, A. Merat, M. Haghshenass, H. Madani, M. Rezaei et al., Plasma lipids in Iranians with sickle cell disease: Hypocholesterolemia in sickle cell anemia and increase of HDL-cholesterol in sickle cell trait, Clinica Chimica Acta, vol.365, issue.1-2, pp.217-237, 2006.
DOI : 10.1016/j.cca.2005.08.022

S. Zorca, L. Freeman, M. Hildesheim, D. Allen, A. Remaley et al., Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension, British Journal of Haematology, vol.113, issue.3, pp.436-481, 2010.
DOI : 10.1093/tropej/41.4.202

M. Seixas, L. Rocha, M. Carvalho, J. Menezes, I. Lyra et al., Levels of high-density lipoprotein cholesterol (HDL-C) among children with steady-state sickle cell disease, Lipids in Health and Disease, vol.9, issue.1, pp.1-9, 2010.
DOI : 10.1186/1476-511X-9-91

J. Shores, J. Peterson, D. Vanderjagt, and R. Glew, Reduced cholesterol levels in African-American adults with sickle cell disease, J Natl Med Assoc, vol.95, pp.813-820, 2003.

M. Buchowski, L. Swift, S. Akohoue, S. Shankar, P. Flakoll et al., Defects in Postabsorptive Plasma Homeostasis of Fatty Acids in Sickle Cell Disease, Journal of Parenteral and Enteral Nutrition, vol.31, issue.4, pp.263-271, 2007.
DOI : 10.3109/10715769609149918

S. Yuditskaya, A. Tumblin, G. Hoehn, G. Wang, S. Drake et al., Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease, Blood, vol.113, issue.5, pp.1122-1130, 2009.
DOI : 10.1182/blood-2008-03-142604

M. Aleluia, C. Da-guarda, R. Santiago, T. Fonseca, F. Neves et al., Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia, Lipids in Health and Disease, vol.3, issue.1, p.74, 2017.
DOI : 10.1371/journal.pone.0002095

Y. Lamarre, M. Lalanne-mistrih, R. M. Lemonne, N. Mougenel, D. Waltz et al., Male Gender, Increased Blood Viscosity, Body Mass Index and Triglyceride Levels Are Independently Associated with Systemic Relative Hypertension in Sickle Cell Anemia, PLoS ONE, vol.120, issue.6, pp.1-6, 2013.
DOI : 10.1371/journal.pone.0066004.t003
URL : https://hal.archives-ouvertes.fr/inserm-00838991

K. Ataga, A. Hinderliter, J. Brittain, S. Jones, H. Xu et al., Association of pro-inflammatory high-density lipoprotein cholesterol with clinical and laboratory variables in sickle cell disease, Hematology, vol.87, issue.5, pp.289-96, 2015.
DOI : 10.1111/j.1365-2141.2006.06110.x

X. Ji, Y. Feng, H. Tian, W. Meng, W. Wang et al., The Mechanism of Proinflammatory HDL Generation in Sickle Cell Disease Is Linked to Cell-Free Hemoglobin via Haptoglobin, PLOS ONE, vol.53, issue.3, p.164264, 2016.
DOI : 10.1371/journal.pone.0164264.s004

R. Ephraim, P. Adu, E. Ake, H. Agbodzakey, P. Adoba et al., Normal Non-HDL Cholesterol, Low Total Cholesterol, and HDL Cholesterol Levels in Sickle Cell Disease Patients in the Steady State: A Case-Control Study of Tema Metropolis, Journal of Lipids, vol.1, issue.2, pp.1-5, 2016.
DOI : 10.1016/j.jacc.2006.09.038

F. Pi-sunyer, D. Becker, C. Bouchard, R. Carleton, G. Colditz et al., Executive summary: clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults ?the evidence report, National Institutes of Health. Obes Res, vol.6, issue.2, pp.51-209, 1998.

M. Amato, V. Guarnotta, and C. Giordano, Body composition assessment for the definition of cardiometabolic risk, J Endocrinol Investig, vol.36, pp.537-580, 2013.

K. Alberti, P. Zimmet, and J. Shaw, The metabolic syndrome???a new worldwide definition, The Lancet, vol.366, issue.9491, pp.1059-62, 2005.
DOI : 10.1016/S0140-6736(05)67402-8

L. Foucan, P. Kangambega, D. Ekouévi, J. Rozet, and J. Bangou-brédent, Lipid profile in an adult population in Guadeloupe, Diabetes Metab, vol.26, pp.473-80, 2000.

J. Daigre, A. Atallah, J. Boissin, G. Jean-baptiste, P. Kangambega et al., The prevalence of overweight and obesity, and distribution of waist circumference, in adults and children in the French Overseas Territories: The PODIUM survey, Diabetes & Metabolism, vol.38, issue.5, pp.404-415, 2012.
DOI : 10.1016/j.diabet.2012.03.008

M. Mukisi-mukaza, A. Elbaz, Y. Samuel-leborgne, L. Kéclard, L. Turdu-chicot et al., Prevalence, clinical features, and risk factors of osteonecrosis of the femoral head among adults with sickle cell disease, Orthopedics, vol.23, pp.357-63, 2000.

M. Mukisi-mukaza, S. Martin, C. Etienne-julan, M. Donkerwolcke, M. Burny et al., Risk factors and impact of orthopaedic monitoring on the outcome of avascular necrosis of the femoral head in adults with sickle cell disease: 215 patients case study with control group, Orthopaedics & Traumatology: Surgery & Research, vol.97, issue.8, pp.814-834, 2011.
DOI : 10.1016/j.otsr.2011.09.011

Y. Lamarre, R. M. Waltz, X. Lalanne-mistrih, M. Tressières, B. Divialle-doumdo et al., Hemorheological risk factors of acute chest syndrome and painful vaso-occlusive crisis in children with sickle cell disease, Haematologica, vol.97, issue.11, pp.1641-1648, 2012.
DOI : 10.3324/haematol.2012.066670
URL : https://hal.archives-ouvertes.fr/inserm-00849038

S. Ballas, J. Larner, E. Smith, S. Surrey, E. Schwartz et al., Rheologic predictors of the severity of the painful sickle cell crisis, Blood, vol.72, pp.1216-1239, 1988.

M. Nouraie, J. Lee, Y. Zhang, T. Kanias, X. Zhao et al., The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe, Haematologica, vol.98, issue.3, pp.464-72, 2013.
DOI : 10.3324/haematol.2012.068965

A. Catapano, Z. Reiner, D. Backer, G. Graham, I. Taskinen et al., EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European atherosclerosis society (EAS), Eur Heart J, vol.32, pp.1769-818, 2011.

O. Ozturk, Y. Can, Z. Yonden, S. Motor, G. Oktay et al., Lipoprotein Subfraction Profile and HDL-Associated Enzymes in Sickle Cell Disease Patients, Lipids, vol.96, issue.18, pp.1217-1243, 2013.
DOI : 10.1073/pnas.96.18.10158

J. Karl, T. Smith, M. Wilson, A. Bukhari, S. Pasiakos et al., Altered metabolic homeostasis is associated with appetite regulation during and following 48-h of severe energy deprivation in adults, Metabolism, vol.65, issue.4, pp.416-443, 2016.
DOI : 10.1016/j.metabol.2015.11.001

G. Veiga, H. Ferreira, A. Sawaya, J. Calado, and T. Florêncio, Dyslipidaemia and Undernutrition in Children from Impoverished Areas of Macei??, State of Alagoas, Brazil, International Journal of Environmental Research and Public Health, vol.103, issue.12, pp.4139-51, 2010.
DOI : 10.1161/CIRCRESAHA.108.178756

A. Singhal, P. Davies, A. Sahota, P. Thomas, and G. Serjeant, Resting metabolic rate in homozygous sickle cell disease, The American Journal of Clinical Nutrition, vol.57, issue.1, pp.32-36, 1993.
DOI : 10.1093/ajcn/57.1.32
URL : https://academic.oup.com/ajcn/article-pdf/57/1/32/23232017/32.pdf

A. Prasad, Malnutrition in sickle cell disease patients, The American Journal of Clinical Nutrition, vol.66, issue.2, pp.423-427, 1997.
DOI : 10.1093/ajcn/66.2.423

C. Cole, M. Nikpay, P. Lau, A. Stewart, R. Davies et al., Adiposity significantly modifies genetic risk for dyslipidemia, Journal of Lipid Research, vol.57, issue.11, pp.2416-2438, 2014.
DOI : 10.1074/jbc.M110.156950
URL : http://jech.bmj.com/content/jech/69/1/A3.1.full.pdf

R. Oka, J. Kobayashi, K. Miura, S. Nagasawa, T. Moriuchi et al., Difference between Fasting and Nonfasting Triglyceridemia; the Influence of Waist Circumference, Journal of Atherosclerosis and Thrombosis, vol.16, issue.5, pp.633-673, 2009.
DOI : 10.5551/jat.406

V. Sahade, S. França, and L. Adan, The influence of weight excess on the postprandial lipemia in adolescents, Lipids in Health and Disease, vol.12, issue.1, pp.1-7, 2013.
DOI : 10.1161/CIR.0b013e3182160726

H. Fan, X. Li, L. Zheng, X. Chen, Q. Lan et al., Abdominal obesity is strongly associated with Cardiovascular Disease and its Risk Factors in Elderly and very Elderly Community-dwelling Chinese, Scientific Reports, vol.58, issue.1, pp.1-9, 2016.
DOI : 10.1093/gerona/58.2.M181

K. Woods, L. Ramsey, L. Callahan, G. Mensah, M. Litaker et al., Body composition in women with sickle cell disease, Ethn Dis, vol.11, pp.30-35, 2001.

L. Wang, R. Gill, T. Pedersen, L. Higgins, J. Newman et al., Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation, Journal of Lipid Research, vol.162, issue.2, pp.204-217, 2009.
DOI : 10.1111/j.1432-1033.1987.tb10676.x
URL : http://www.jlr.org/content/50/2/204.full.pdf

P. Monnet, F. Kane, D. Konan-waidhet, S. Akpona, K. J. Diafouka et al., Evaluation of atherogenic risk in homozygous sickle cell disease: study of lipid and apolipoprotein AI and B plasma levels, Bull Soc Pathol Exot, vol.89, pp.278-81, 1996.

D. Monnet, N. Edjeme, K. Ndri, M. Hauhouot-attoungbre, H. Ahibo et al., Lipoprotein (a) and acute phase inflammation proteins in homozygous sickle cell disease, Ann Biol Clin, vol.60, pp.101-104, 2002.

P. Milner, A. Kraus, J. Sebes, L. Sleeper, K. Dukes et al., Sickle Cell Disease as a Cause of Osteonecrosis of the Femoral Head, New England Journal of Medicine, vol.325, issue.21, pp.1476-81, 1991.
DOI : 10.1056/NEJM199111213252104

J. Moskal, R. Topping, and L. Franklin, Hypercholesterolemia: an association with osteonecrosis of the femoral head, Am J OrthopBelle Mead NJ), vol.26, pp.609-621, 1997.

D. Zhao, M. Yu, K. Hu, W. Wang, L. Yang et al., Prevalence of Nontraumatic Osteonecrosis of the Femoral Head and its Associated Risk Factors in the Chinese Population: Results from a Nationally Representative Survey, Chinese Medical Journal, vol.128, issue.21, pp.2843-50, 2015.
DOI : 10.4103/0366-6999.168017

K. Miyanishi, T. Yamamoto, T. Irisa, Y. Noguchi, Y. Sugioka et al., Increased level of apolipoprotein B/apolipoprotein A1 ratio as a potential risk for osteonecrosis, Annals of the Rheumatic Diseases, vol.58, issue.8, pp.514-520, 1999.
DOI : 10.1136/ard.58.8.514

T. Kuroda, N. Tanabe, A. Wakamatsu, C. Takai, H. Sato et al., High triglyceride??is a risk factor for silent osteonecrosis of the femoral head??in systemic lupus erythematosus, Clinical Rheumatology, vol.115, issue.12, pp.2071-2078, 2015.
DOI : 10.1161/CIRCULATIONAHA.106.637793

K. E. Bergmann, Non-HDL cholesterol and evaluation of cardiovascular disease risk, pp.64-71, 2010.

J. Jaskolowski, C. Ritz, A. Sjödin, A. Astrup, P. Szecsi et al., Weekday variation in triglyceride concentrations in 1.8 million blood samples, Journal of Lipid Research, vol.198, issue.6, pp.1204-1217, 2017.
DOI : 10.1016/S0002-9343(01)00836-1